Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134797) titled 'The Role of Intravenous Iron Agents in Pre-operative Optimization for Patients Undergoing Elective Gastrointestinal Surgery' on Oct. 21.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University
Condition:
1. Crohn's disease
2. Iron deficiency anemia
Intervention:
intervention group:During the 6-week preoperative EEN period, experimental patients receive 1-3 doses of ferric carboxymaltose (Ferinject?, Vifor Pharma, FCM).
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-10-30
Target Sample Siz...